Extended treatment tested for inflammatory bowel disease
NCT ID NCT03648541
Summary
This study followed 79 adults with moderate to severe ulcerative colitis who had already participated in earlier trials of the drug spesolimab. Its main goal was to check the long-term safety of continuing this treatment. Researchers also looked at whether patients maintained symptom relief over an extended period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLITIS, ULCERATIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AKH - Medical University of Vienna
Vienna, 1090, Austria
-
Asklepios Kliniken Westklinikum Hamburg
Hamburg, 22559, Germany
-
Azienda Ospedaliera Universitaria di Padova
Padua, 35128, Italy
-
Centre Hospitalier Universitaire de Liège
Liège, 4000, Belgium
-
Columbia University Medical Center-New York Presbyterian Hospital
New York, New York, 10032, United States
-
Digestive Disease Specialists Inc
Oklahoma City, Oklahoma, 73112, United States
-
Doncaster Royal Infirmary
Doncaster, DN2 5LT, United Kingdom
-
Emory University
Atlanta, Georgia, 30322, United States
-
FSB Instit. HC Irkutsk Scient.Cent. Sibirian Branch of Russ. Acad. Scien.
Irkutsk, 664033, Russia
-
Federal State Budgetary Institution " State Scientific Center of Coloproctology" MOH Russia
Moscow, 123423, Russia
-
Guy's Hospital
London, SE1 9RT, United Kingdom
-
Hospital Politècnic La Fe
Valencia, 46026, Spain
-
Hospital Virgen del Rocío
Seville, 41013, Spain
-
Hunter Holmes McGuire VA Medical Center
Richmond, Virginia, 23249, United States
-
Hyogo College of Medicine Hospital
Hyogo, Nishinomiya, 663-8501, Japan
-
Inje University Haeundae Paik Hospital
Busan, 48108, South Korea
-
Istituto Clinico Humanitas
Rozzano (MI), 20089, Italy
-
Klinikum Esslingen GmbH
Esslingen am Neckar, 73730, Germany
-
Medical Research Center of Connecticut, LLC
Hamden, Connecticut, 06518, United States
-
Medizinische Hochschule Hannover
Hanover, 30625, Germany
-
Military Medical Academy n.a. C. M. Kirov, St. Petersburg
Saint Petersburg, 194044, Russia
-
National Medical Institute MSWiA
Warsaw, 02-507, Poland
-
Ofuna Chuo Hospital
Kanagawa, Kamakura, 247-0056, Japan
-
Ordensklinikum Linz GmbH - Barmherzige Schwestern
Linz, 4010, Austria
-
Sapporo Higashi Tokushukai Hospital
Hokkaido, Sapporo, 065-0033, Japan
-
Sapporo Tokushukai Hospital
Hokkaido, Sapporo, 004-0041, Japan
-
Southern Star Research Institute, LLC
San Antonio, Texas, 78229, United States
-
Texas Digestive Disease Consultants - Southlake
Southlake, Texas, 76092, United States
-
Tokyo Medical and Dental University Hospital
Tokyo, Bunkyo-ku, 113-8519, Japan
-
Tokyo Yamate Medical Center
Tokyo, Shinjuku, 169-0073, Japan
-
UZ Leuven
Leuven, 3000, Belgium
-
University of Chicago
Chicago, Illinois, 60637, United States
-
Universitätsklinikum Erlangen
Erlangen, 91054, Germany
-
Universitätsklinikum Schleswig-Holstein, Campus Kiel
Kiel, 24105, Germany
-
Universitätsklinikum Ulm
Ulm, 89081, Germany
-
Victoria Hospital (LHSC)
London, Ontario, N6A 5W9, Canada
-
Whiston Hospital
Prescot, L35 5DR, United Kingdom
-
Yeungnam University Medical Center
Daegu, 42415, South Korea
Conditions
Explore the condition pages connected to this study.